REC114
geneOn this page
Also known as LOC283677FLJ27520FLJ36860FLJ44083CT147
Summary
REC114 (REC114 meiotic recombination protein, HGNC:25065) is a protein-coding gene on chromosome 15q24.1, encoding Meiotic recombination protein REC114 (Q7Z4M0). Required for DNA double-strand breaks (DSBs) formation in unsynapsed regions during meiotic recombination.
The protein encoded by this gene is orthologous to the mouse meiotic recombination protein REC114, which is involved in DNA double-strand break formation during meiosis. The encoded protein is conserved in most eukaryotes and was first discovered and characterized in yeast.
Source: NCBI Gene 283677 — RefSeq curated summary.
At a glance
- Gene–disease (curated): oocyte maturation defect 10 (Strong, GenCC)
- GWAS associations: 7
- Clinical variants (ClinVar): 59 total — 2 pathogenic
- Phenotypes (HPO): 6
- MANE Select transcript:
NM_001042367
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25065 |
| Approved symbol | REC114 |
| Name | REC114 meiotic recombination protein |
| Location | 15q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC283677, FLJ27520, FLJ36860, FLJ44083, CT147 |
| Ensembl gene | ENSG00000183324 |
| Ensembl biotype | protein_coding |
| OMIM | 618421 |
| Entrez | 283677 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000331090, ENST00000560581
RefSeq mRNA: 2 — MANE Select: NM_001042367
NM_001042367, NM_001348772
CCDS: CCDS45296, CCDS86474
Canonical transcript exons
ENST00000331090 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001295789 | 73473832 | 73473921 |
| ENSE00001308393 | 73556302 | 73556391 |
| ENSE00001317513 | 73540485 | 73540568 |
| ENSE00001330489 | 73550938 | 73551150 |
| ENSE00002537921 | 73443164 | 73443344 |
| ENSE00002556865 | 73559752 | 73560013 |
Expression profiles
Bgee: expression breadth broad, 99 present calls, max score 95.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0641 / max 50.5215, expressed in 6 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147602 | 0.0641 | 6 |
Top tissues by expression
213 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 95.95 | gold quality |
| secondary oocyte | CL:0000655 | 93.19 | gold quality |
| right testis | UBERON:0004534 | 91.62 | gold quality |
| left testis | UBERON:0004533 | 91.52 | gold quality |
| sperm | CL:0000019 | 90.91 | gold quality |
| testis | UBERON:0000473 | 89.46 | gold quality |
| adult organism | UBERON:0007023 | 86.74 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.12 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.95 | gold quality |
| tibialis anterior | UBERON:0001385 | 78.96 | silver quality |
| right atrium auricular region | UBERON:0006631 | 76.96 | gold quality |
| cardiac atrium | UBERON:0002081 | 76.45 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 74.38 | gold quality |
| ileal mucosa | UBERON:0000331 | 67.49 | gold quality |
| deltoid | UBERON:0001476 | 66.08 | silver quality |
| buccal mucosa cell | CL:0002336 | 65.92 | gold quality |
| pancreatic ductal cell | CL:0002079 | 64.86 | silver quality |
| parotid gland | UBERON:0001831 | 64.63 | gold quality |
| apex of heart | UBERON:0002098 | 63.51 | gold quality |
| biceps brachii | UBERON:0001507 | 61.73 | gold quality |
| oral cavity | UBERON:0000167 | 59.60 | gold quality |
| heart | UBERON:0000948 | 59.51 | gold quality |
| upper leg skin | UBERON:0004262 | 59.43 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 59.13 | gold quality |
| calcaneal tendon | UBERON:0003701 | 58.66 | gold quality |
| endothelial cell | CL:0000115 | 57.81 | gold quality |
| cartilage tissue | UBERON:0002418 | 57.79 | gold quality |
| gingiva | UBERON:0001828 | 57.73 | gold quality |
| skin of hip | UBERON:0001554 | 56.70 | silver quality |
| gingival epithelium | UBERON:0001949 | 56.67 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.26 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ZNF699
Literature-anchored findings (GeneRIF, showing 3)
- In Japanese individuals, combined genotyping for the associated variants thus far identified; that is, HLA-A*02:06, TLR3 rs3775296 T/T and Rec114 rs16957893 CG, may help to predict the risk for cold medicine-related Stevens-Johnson syndrome /TEN with severe ocular complications (PMID:28100913)
- Homozygous mutations in REC114 cause female infertility characterised by multiple pronuclei formation and early embryonic arrest. (PMID:31704776)
- A bi-allelic REC114 loss-of-function variant causes meiotic arrest and nonobstructive azoospermia. (PMID:38148155)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rec114 | ENSDARG00000069781 |
| mus_musculus | Rec114 | ENSMUSG00000074269 |
| rattus_norvegicus | Rec114 | ENSRNOG00000009332 |
Protein
Protein identifiers
Meiotic recombination protein REC114 — Q7Z4M0 (reviewed: Q7Z4M0)
All UniProt accessions (2): H0YKR2, Q7Z4M0
UniProt curated annotations — full annotation on UniProt →
Function. Required for DNA double-strand breaks (DSBs) formation in unsynapsed regions during meiotic recombination. Probably acts by forming a complex with IHO1 and MEI4, which activates DSBs formation in unsynapsed regions, an essential step to ensure completion of synapsis. Required for spermatogenesis. Required for oogenesis.
Subunit / interactions. Part of the MCD recombinosome complex, at least composed of IHO1, REC114 and MEI4. Forms a complex with MEI4; the interaction is required for MEI4 stability. Interacts (via C-terminal domain) with MEI4 (via N-terminal domain). Interacts with IHO1. Interacts with ANKRD31; the interaction is direct.
Subcellular location. Chromosome.
Disease relevance. Oocyte/zygote/embryo maturation arrest 10 (OZEMA10) [MIM:619176] An autosomal recessive infertility disorder due to abnormal fertilization of mature oocytes, with development of multiple pronuclei or absent pronucleus, and early embryonic arrest. The gene represented in this entry is involved in disease pathogenesis.
Similarity. Belongs to the REC114 family.
RefSeq proteins (2): NP_001035826, NP_001335701 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029168 | REC114L | Family |
Pfam: PF15165
UniProt features (6 total): sequence variant 3, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z4M0-F1 | 73.71 | 0.41 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 51 (showing top):
GOBP_OOGENESIS, GOBP_MALE_GAMETE_GENERATION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_FEMALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_MEIOTIC_CELL_CYCLE, GOBP_CELL_CYCLE_PROCESS, GOBP_DNA_METABOLIC_PROCESS, GOBP_DNA_RECOMBINATION, GOCC_NUCLEAR_CHROMOSOME, GOCC_CONDENSED_NUCLEAR_CHROMOSOME, PILON_KLF1_TARGETS_UP, GOBP_MEIOTIC_DNA_DOUBLE_STRAND_BREAK_FORMATION, MADAN_DPPA4_TARGETS
GO Biological Process (6): DNA recombination (GO:0006310), spermatogenesis (GO:0007283), meiotic DNA double-strand break formation (GO:0042138), oogenesis (GO:0048477), cell differentiation (GO:0030154), meiotic cell cycle (GO:0051321)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA metabolic process | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| meiosis I cell cycle process | 1 |
| germ cell development | 1 |
| female gamete generation | 1 |
| cellular developmental process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| binding | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1176 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| REC114 | MEI4 | A8MW99 | 997 |
| REC114 | CD151 | P48509 | 983 |
| REC114 | IHO1 | Q8IYA8 | 953 |
| REC114 | ANKRD31 | Q8N7Z5 | 940 |
| REC114 | MEI1 | Q5TIA1 | 906 |
| REC114 | SPO11 | Q9Y5K1 | 866 |
| REC114 | TOP6BL | Q8N6T0 | 824 |
| REC114 | HORMAD1 | Q86X24 | 719 |
| REC114 | SKIC8 | Q9GZS3 | 690 |
| REC114 | REC8 | O95072 | 673 |
| REC114 | MSH4 | O15457 | 667 |
| REC114 | NEK9 | Q8TD19 | 641 |
| REC114 | ADARB1 | P78555 | 641 |
| REC114 | PRDM9 | Q9NQV7 | 627 |
| REC114 | HFM1 | A2PYH4 | 620 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| REC114 | MEI4 | psi-mi:“MI:0915”(physical association) | 0.590 |
| MEI4 | REC114 | psi-mi:“MI:0915”(physical association) | 0.590 |
| M | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): REC114 (Affinity Capture-MS), REC114 (Co-fractionation), REC114 (Co-fractionation), REC114 (Co-fractionation)
ESM2 similar proteins: A0A1L8ENT6, A2BGP7, A2CJ06, B1H1W9, F6RRD7, O00124, O55036, P54274, Q1LV50, Q1LWH4, Q1T7B8, Q28HU3, Q3KNJ2, Q3U1D0, Q3US16, Q4KLN8, Q4V832, Q5I0E6, Q5I2W8, Q5NVA9, Q5RA37, Q5RET9, Q5XI46, Q5ZIN2, Q6AYI4, Q6DRL4, Q6IQ49, Q6IRN0, Q6NV18, Q6P1H6, Q7Z2Z1, Q7Z4M0, Q8BJW7, Q8BKT3, Q8BMG1, Q8BMI4, Q8BQ33, Q8IXW5, Q8K1J5, Q8VC34
Diamond homologs: Q7Z4M0, Q9CWH4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 7 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 996125 | NM_001042367.2(REC114):c.397T>G (p.Cys133Gly) | Pathogenic |
| 996126 | NM_001042367.2(REC114):c.546+5G>A | Pathogenic |
SpliceAI
1471 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:73540581:C:G | donor_gain | 1.0000 |
| 15:73551114:G:T | donor_gain | 1.0000 |
| 15:73551151:G:GG | donor_gain | 1.0000 |
| 15:73463303:GC:G | donor_gain | 0.9900 |
| 15:73473830:A:G | acceptor_gain | 0.9900 |
| 15:73483847:G:GT | donor_gain | 0.9900 |
| 15:73540107:A:G | donor_gain | 0.9900 |
| 15:73540576:T:G | donor_gain | 0.9900 |
| 15:73551148:GGA:G | donor_gain | 0.9900 |
| 15:73551149:GA:G | donor_gain | 0.9900 |
| 15:73551149:GAG:G | donor_gain | 0.9900 |
| 15:73556300:A:AG | acceptor_gain | 0.9900 |
| 15:73556301:G:GG | acceptor_gain | 0.9900 |
| 15:73559750:A:AG | acceptor_gain | 0.9900 |
| 15:73559751:G:GG | acceptor_gain | 0.9900 |
| 15:73443342:AAGGT:A | donor_loss | 0.9800 |
| 15:73443343:AG:A | donor_loss | 0.9800 |
| 15:73443344:GG:G | donor_loss | 0.9800 |
| 15:73443345:GT:G | donor_loss | 0.9800 |
| 15:73443346:T:G | donor_loss | 0.9800 |
| 15:73550936:A:C | acceptor_loss | 0.9800 |
| 15:73551114:G:GT | donor_gain | 0.9800 |
| 15:73551146:CTGGA:C | donor_gain | 0.9800 |
| 15:73551147:TGGAG:T | donor_loss | 0.9800 |
| 15:73551148:GGAGT:G | donor_loss | 0.9800 |
| 15:73551152:TAAG:T | donor_loss | 0.9800 |
| 15:73551153:AAG:A | donor_loss | 0.9800 |
| 15:73551154:A:AC | donor_loss | 0.9800 |
| 15:73551155:G:GG | donor_gain | 0.9800 |
| 15:73555198:T:TA | donor_gain | 0.9800 |
AlphaMissense
1703 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:73550966:T:C | F121S | 0.997 |
| 15:73550954:T:C | F117S | 0.993 |
| 15:73550965:T:C | F121L | 0.993 |
| 15:73550967:C:A | F121L | 0.993 |
| 15:73550967:C:G | F121L | 0.993 |
| 15:73550957:G:C | R118P | 0.992 |
| 15:73540546:T:C | L104P | 0.990 |
| 15:73559888:T:C | L258P | 0.988 |
| 15:73540498:T:A | L88H | 0.987 |
| 15:73443246:T:A | W21R | 0.986 |
| 15:73443246:T:C | W21R | 0.986 |
| 15:73473899:T:A | I76N | 0.986 |
| 15:73540519:T:C | L95S | 0.986 |
| 15:73550953:T:C | F117L | 0.986 |
| 15:73550955:T:A | F117L | 0.986 |
| 15:73550955:T:G | F117L | 0.986 |
| 15:73550966:T:G | F121C | 0.985 |
| 15:73551010:T:C | C136R | 0.985 |
| 15:73559854:T:C | F247L | 0.985 |
| 15:73559856:C:A | F247L | 0.985 |
| 15:73559856:C:G | F247L | 0.985 |
| 15:73559836:T:C | C241R | 0.984 |
| 15:73551012:T:G | C136W | 0.983 |
| 15:73443248:G:C | W21C | 0.982 |
| 15:73443248:G:T | W21C | 0.982 |
| 15:73473887:G:T | G72V | 0.982 |
| 15:73473869:T:C | L66P | 0.981 |
| 15:73540492:T:C | F86S | 0.981 |
| 15:73551003:C:G | C133W | 0.981 |
| 15:73559855:T:C | F247S | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1000068084 (15:73443584 A>G), RS1000084866 (15:73516678 A>G), RS1000121537 (15:73443874 TAG>T), RS1000143976 (15:73502169 A>G,T), RS1000150700 (15:73457173 G>A), RS1000229782 (15:73505646 C>A), RS1000258903 (15:73502422 T>G), RS1000261292 (15:73486317 C>T), RS1000280816 (15:73455317 G>T), RS1000326659 (15:73557132 C>T), RS1000347189 (15:73492260 C>T), RS1000358947 (15:73463215 C>T), RS1000396329 (15:73520494 T>C,G), RS1000408264 (15:73545614 G>A), RS1000433433 (15:73523821 C>CTAG)
Disease associations
OMIM: gene MIM:618421 | disease phenotypes: MIM:619176
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| oocyte maturation defect 10 | Strong | Autosomal recessive |
Mondo (1): oocyte maturation defect 10 (MONDO:0030925)
Orphanet (0):
HPO phenotypes
6 total (6 of 6 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0003581 | Adult onset |
| HP:0005268 | Miscarriage |
| HP:0008222 | Female infertility |
| HP:0033712 | Repeated implantation failure |
| HP:4000008 | Formation of multiple pronuclei during fertilization |
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004072_1 | Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications | 2.000000e-08 |
| GCST005956_11 | Waist-to-hip ratio adjusted for BMI | 1.000000e-08 |
| GCST005962_52 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 5.000000e-07 |
| GCST006061_48 | Atrial fibrillation | 2.000000e-27 |
| GCST006061_62 | Atrial fibrillation | 1.000000e-27 |
| GCST007277_20 | Tourette syndrome | 7.000000e-06 |
| GCST007431_51 | Lung function (FEV1/FVC) | 7.000000e-10 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006997 | response to cold medicine |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0004713 | FEV/FVC ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: oocyte maturation defect 10
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): oocyte maturation defect 10, Stevens-Johnson syndrome, toxic epidermal necrolysis